• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEUROPACE, INC. NEUROPACE RNS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEUROPACE, INC. NEUROPACE RNS SYSTEM Back to Search Results
Model Number RNS-320-K - FGI
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Wound Dehiscence (1154); Bacterial Infection (1735); Purulent Discharge (1812); Impaired Healing (2378)
Event Date 10/20/2023
Event Type  Injury  
Manufacturer Narrative
(b)(4).The explanted product was not returned to neuropace for analysis.
 
Event Description
On (b)(6) 2023, the patient reported incisional tenderness and the sensation of "pressure" along with slight redness.The patient was started on cephalexin orally.At the wound check visit on (b)(6) 2023, a small wound opening and moderate amount of purulent drainage was observed.The patient was admitted to the hospital for debridement and washout of the incision site.Cultures were collected resulting in growth of pseudomonas, while the patient was on iv antibiotics.Iv antibiotic zosyn was prescribed and continued postoperatively.The patient developed neutropenia while on zosyn and therefore the antibiotic was changed to cefepime.On 10/20/2023, the incision site had failed to fully close, the rns neurostimulator and hardware were explanted.Treatment included continuation of antibiotics.Antibiotics treatment details were as follows: cephalexin (b)(6) 2023, cefepime (b)(6) 2023, vancomycin (b)(6) 2023, piperacillin-tazobactam (b)(6) 2023, cefepime (b)(6) 2023, piperacillin-tazobactam (b)(6) 2023, ciprofloxacin (b)(6) 2023-eot (b)(6) 2023.The patient continues to recover from the infection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROPACE RNS SYSTEM
Type of Device
NEUROPACE RNS SYSTEM
Manufacturer (Section D)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer (Section G)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer Contact
ramona gonis
455 n. bernardo ave.
mountain view, CA 94043
5108822607
MDR Report Key18173629
MDR Text Key328566313
Report Number3004426659-2023-00054
Device Sequence Number1
Product Code PFN
UDI-Device Identifier00855547005366
UDI-Public010085554700536617240110
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100026
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Nurse
Type of Report Initial
Report Date 11/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model NumberRNS-320-K - FGI
Device Catalogue Number1008191
Device Lot Number33183-1-1-1
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/20/2023
Initial Date FDA Received11/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age48 YR
Patient SexFemale
-
-